SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2− breast cancer
K Li(The Affiliated Yongchuan Hospital of Chongqing Medical University), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Zhaofu Tan(The Affiliated Yongchuan Hospital of Chongqing Medical University), Ailin Lan(The Affiliated Yongchuan Hospital of Chongqing Medical University), Haochen Yu(St. Michael's Hospital), Maria Lauda Tomasi(Cedars-Sinai Medical Center), Dan Shu(The Ohio State University), Meiying Shen, Han Li(Central South University), Wenjie Zhang(Nanjing Tech University), Man Huang(Chongqing University), Aishun Jin
Cited by 10
Related Papers
Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
|The International Journal of Neuropsychopharmacology|2011|430
Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor
|Oncology Reports|2019|223
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
|Molecular Therapy|2017|147